MLTX
Price
$48.90
Change
+$0.62 (+1.28%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
3.06B
28 days until earnings call
SYRE
Price
$15.94
Change
-$0.61 (-3.69%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
998.85M
20 days until earnings call
Interact to see
Advertisement

MLTX vs SYRE

Header iconMLTX vs SYRE Comparison
Open Charts MLTX vs SYREBanner chart's image
MoonLake Immunotherapeutics
Price$48.90
Change+$0.62 (+1.28%)
Volume$6.42K
Capitalization3.06B
Spyre Therapeutics
Price$15.94
Change-$0.61 (-3.69%)
Volume$12.02K
Capitalization998.85M
MLTX vs SYRE Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. SYRE commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a StrongBuy and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (MLTX: $48.28 vs. SYRE: $16.55)
Brand notoriety: MLTX and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 162% vs. SYRE: 99%
Market capitalization -- MLTX: $3.06B vs. SYRE: $998.85M
MLTX [@Biotechnology] is valued at $3.06B. SYRE’s [@Biotechnology] market capitalization is $998.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 3 TA indicator(s) are bullish while SYRE’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 3 bullish, 4 bearish.
  • SYRE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а +0.88% price change this week, while SYRE (@Biotechnology) price change was +6.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.07B) has a higher market cap than SYRE($999M). MLTX YTD gains are higher at: -9.732 vs. SYRE (-31.443). MLTX has higher annual earnings (EBITDA): -168.14M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. MLTX (480M). SYRE has less debt than MLTX: SYRE (0) vs MLTX (75.6M). MLTX (0) and SYRE (0) have equivalent revenues.
MLTXSYREMLTX / SYRE
Capitalization3.07B999M307%
EBITDA-168.14M-214.36M78%
Gain YTD-9.732-31.44331%
P/E RatioN/A1.72-
Revenue00-
Total Cash480M565M85%
Total Debt75.6M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXSYRE
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGVBX26.270.02
+0.08%
American Funds Global Insight 529-C
MMUJX23.92N/A
N/A
MFS Utilities R4
NVLIX65.21N/A
N/A
Nuveen Winslow Large-Cap Growth ESG I
RYOTX11.46N/A
N/A
Royce Micro-Cap Invmt
VEILX15.37N/A
N/A
VELA International A

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XNCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+1.24%
XNCR - MLTX
45%
Loosely correlated
-0.54%
IDYA - MLTX
45%
Loosely correlated
-0.74%
XENE - MLTX
44%
Loosely correlated
+0.92%
CLDX - MLTX
44%
Loosely correlated
+0.98%
CRNX - MLTX
43%
Loosely correlated
-1.05%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-3.56%
CGON - SYRE
58%
Loosely correlated
+0.26%
BEAM - SYRE
58%
Loosely correlated
+2.66%
XNCR - SYRE
55%
Loosely correlated
-0.54%
APGE - SYRE
53%
Loosely correlated
+4.19%
IDYA - SYRE
53%
Loosely correlated
-0.74%
More